On Friday, the U.S. Food and Drug Administration granted emergency use authorization for an updated version of Novavax’s (NASDAQ: NVAX) […]
FDA Authorizes Novavax (NASDAQ: NVAX) Updated COVID Vaccine Targeting JN.1 Strain Read More »
On Thursday, Novavax (NASDAQ: NVAX) trimmed its annual revenue forecast again and said it would pare back its presence in
Novavax (NASDAQ: NVAX) Slashes 2024 Revenue Guidance Again, To Cut European Presence Read More »
Novavax (NASDAQ: NVAX) stock climbed almost 50% in intraday trading Monday after TD Cowen analyst raised its price target. Brendan
Novavax (NASDAQ: NVAX) Stock Skyrockets as TD Cowen Analyst Lifts Price Target Read More »
Novavax (NASDAQ: NVAX) stock soared almost 100% in intraday trading after signing a COVID-19 license deal with Sanofi and withdrawing
Shares of Novavax, Inc. (NASDAQ: NVAX) surged 28.15% on Monday following two major announcements: the revised agreement with the Government
Novavax, Inc. (NASDAQ: NVAX) Shares Surge on Two Key Announcements Read More »
